相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical Characteristics and Prognostic Factors in Ankylosing Spondylitis Associated Uveitis
Ji Hwan Lee et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2019)
Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III
Eric B. Suhler et al.
OPHTHALMOLOGY (2018)
Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1
Philip J. Mease et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Efficacy of golimumab on recurrent uveitis in HLA-B27-positive ankylosing spondylitis
Serpil Yazgan et al.
INTERNATIONAL OPHTHALMOLOGY (2017)
Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial
Peter Nash et al.
LANCET (2017)
Efficacy and safety of immunomodulatory drugs in patients with anterior uveitis: A systematic literature review
Alejandro Gomez-Gomez et al.
MEDICINE (2017)
Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis
P. Mease et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors
Dafna Gladman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Ocular involvement in patients with spondyloarthritis
Ana Beatriz Santos Bacchiega et al.
RHEUMATOLOGY (2017)
Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study
Iain B. McInnes et al.
RHEUMATOLOGY (2017)
Eight-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Spondyloarthritis: A Multicenter Retrospective Analysis
Ennio Giulio Favalli et al.
ARTHRITIS CARE & RESEARCH (2017)
Secukinumab and Sustained Improvement in Signs and Symptoms of Patients With Active Ankylosing Spondylitis Through Two Years: Results From a Phase III Study
H. Marzo-Ortega et al.
ARTHRITIS CARE & RESEARCH (2017)
Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register
Elisabeth Lie et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
Desiree van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Anti-TNFα, Treatment for HLA-B27-Positive Ankylosing Spondylitis-Related Uveitis
Mirinae Kim et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2016)
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)
Christopher J. Edwards et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
A Phase III, Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis: Results of the PALACE 2 Trial
Maurizio Cutolo et al.
JOURNAL OF RHEUMATOLOGY (2016)
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial
Quan Dong Nguyen et al.
LANCET (2016)
Adalimumab in Patients with Active Noninfectious Uveitis
Glenn J. Jaffe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Golimumab in refractory uveitis related to spondyloarthritis. Multicenter study of 15 patients
Vanesa Calvo-Rio et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)
Observed Incidence of Uveitis Following Certolizumab Pegol Treatment in Patients With Axial Spondyloarthritis
M. Rudwaleit et al.
ARTHRITIS CARE & RESEARCH (2016)
Secukinumab Provides Significant and Sustained Inhibition of Joint Structural Damage in a Phase III Study of Active Psoriatic Arthritis
Desiree van der Heijde et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Certolizumab Pegol, a New Anti-TNF-α in the Armamentarium against Ocular Inflammation
Victor Llorenc et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2016)
Autoimmune uveitis: clinical, pathogenetic, and therapeutic features
Marcella Prete et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2016)
The intestinal microbiome in spondyloarthritis
Tejpal Gill et al.
CURRENT OPINION IN RHEUMATOLOGY (2015)
Uveitis in adults: What do rheumatologists need to know?
Pascal Seve et al.
JOINT BONE SPINE (2015)
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Iain B. McInnes et al.
LANCET (2015)
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
Philip J. Mease et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Spectrum of Uveitis in a German Tertiary Center: Review of 474 Consecutive Patients
Rafael S. Grajewski et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2015)
Acute Anterior Uveitis and Spondyloarthritis: More Than Meets the Eye
Muhammad A. Khan et al.
CURRENT RHEUMATOLOGY REPORTS (2015)
Effect of Certolizumab Pegol Over Ninety-Six Weeks in Patients With Axial Spondyloarthritis
J. Sieper et al.
ARTHRITIS & RHEUMATOLOGY (2015)
A novel evidence-based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis: the DUET (Dublin Uveitis Evaluation Tool)
Muhammad Haroon et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Indirect Comparison Between Subcutaneous Biologic Agents in Ankylosing Spondylitis
Alberto Migliore et al.
CLINICAL DRUG INVESTIGATION (2015)
Uveitis in Spondyloarthritis: An Overview
Fabrizio Cantini et al.
JOURNAL OF RHEUMATOLOGY (2015)
Intraocular Implants for the Treatment of Autoimmune Uveitis
Darren J. Lee
JOURNAL OF FUNCTIONAL BIOMATERIALS (2015)
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial
Iain B. McInnes et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
Christopher Ritchlin et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)
Denis Poddubnyy et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Treatment of seronegative spondyloarthropathy-associated uveitis with golimumab: retrospective case series
Sepideh Faez et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2014)
Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a large US claims database
Daniel Wendling et al.
CURRENT MEDICAL RESEARCH AND OPINION (2014)
A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I
Kyungmin Lee et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Paradoxical effects of anti-TNF-α agents in inflammatory diseases
Daniel Wendling et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2014)
Adalimumab Significantly Reduces the Recurrence Rate of Anterior Uveitis in Patients with Ankylosing Spondylitis
J. Christiaan van denderen et al.
JOURNAL OF RHEUMATOLOGY (2014)
Golimumab as Rescue Therapy for Refractory Immune-Mediated Uveitis: A Three-Center Experience
Miguel Cordero-Coma et al.
MEDIATORS OF INFLAMMATION (2014)
Long-term Treatment with Golimumab for Severe Uveitis
Elisabetta Miserocchi et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2014)
Expert Panel Recommendations for the Use of Anti-Tumor Necrosis Factor Biologic Agents in Patients with Ocular Inflammatory Disorders
Grace Levy-Clarke et al.
OPHTHALMOLOGY (2014)
Update on the use of systemic biologic agents in the treatment of noninfectious uveitis
Sirichai Pasadhika et al.
BIOLOGICS-TARGETS & THERAPY (2014)
Inefficacy or Paradoxical Effect? Uveitis in Ankylosing Spondylitis Treated with Etanercept
Bernd Raffeiner et al.
CASE REPORTS IN MEDICINE (2014)
A three-centre experience with adalimumab for the treatment of non-infectious uveitis
Bianca Carola Dobner et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2013)
The critical importance of epigenetics in autoimmunity
Qianjin Lu
JOURNAL OF AUTOIMMUNITY (2013)
The eye: A window to the soul of the immune system
V. L. Perez et al.
JOURNAL OF AUTOIMMUNITY (2013)
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial
Iain B. McInnes et al.
LANCET (2013)
Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci
Adrian Cortes et al.
NATURE GENETICS (2013)
Systematic Review of Anti-Tumor Necrosis Factor-alpha Therapy for Treatment of Immune-mediated Uveitis
Miguel Cordero-Coma et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2013)
Secukinumab in the Treatment of Noninfectious Uveitis: Results of Three Randomized, Controlled Clinical Trials
Andrew D. Dick et al.
OPHTHALMOLOGY (2013)
Safety and Efficacy of Topical Infliximab in a Mouse Model of Ocular Surface Scarring
Giulio Ferrari et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Effectiveness of Topical Infliximab in a Mouse Model of Experimental Dry Eye
Zhengri Li et al.
CORNEA (2012)
The role of biologic agents in the management of non-infectious uveitis
Jangwon Heo et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Sex differences and genomics in autoimmune diseases
Shashi Amur et al.
JOURNAL OF AUTOIMMUNITY (2012)
Primed for inflammation: enthesis-resident T cells
Rik J. Lories et al.
NATURE MEDICINE (2012)
Immunomodulatory Effect of the Topical Ophthalmic Janus Kinase Inhibitor Tofacitinib (CP-690,550) in Patients with Dry Eye Disease
Jing-Feng Huang et al.
OPHTHALMOLOGY (2012)
Management and evaluation of extra-articular manifestations in spondyloarthritis
Irene E. van der Horst-Bruinsma et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2012)
What Is New HLA-B27 Acute Anterior Uveitis?
Denis Wakefield et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2011)
INTRAVITREAL TUMOR NECROSIS FACTOR INHIBITORS IN THE TREATMENT OF REFRACTORY DIABETIC MACULAR EDEMA A Pilot Study From the Pan-American Collaborative Retina Study Group
Lihteh Wu et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2011)
The Multicenter Uveitis Steroid Treatment Trial: Rationale, Design, and Baseline Characteristics
John H. Kempen et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
From HLA-B27 to spondyloarthritis: a journey through the ER
Robert A. Colbert et al.
IMMUNOLOGICAL REVIEWS (2010)
Current approach in diagnosis and management of anterior uveitis
Rupesh V. Agrawal et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2010)
Cyclosporine for Ocular Inflammatory Diseases
R. Oktay Kacmaz et al.
OPHTHALMOLOGY (2010)
Mechanisms of TNFα regulation in uveitis: Focus on RNA-binding proteins
Tarnjit K. Khera et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2010)
ADVERSE EVENTS AFTER INTRAVITREAL INFLIXIMAB (REMICADE)
Monica Giganti et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
INTRAVITREAL INFLIXIMAB FOR THE TREATMENT OF SIGHT-THREATENING CHRONIC NONINFECTIOUS UVEITIS
Mohsen Farvardin et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
INTRAVITREAL INFLIXIMAB IN PATIENTS WITH MACULAR DEGENERATION WHO ARE NONRESPONDERS TO ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY
Luis Arias et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
M. Rudwaleit et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Infliximab Therapy for Refractory Uveitis: 2-Year Results of a Prospective Trial
Eric B. Suhler et al.
ARCHIVES OF OPHTHALMOLOGY (2009)
Methotrexate for Ocular Inflammatory Diseases
Sapna Gangaputra et al.
OPHTHALMOLOGY (2009)
Adalimumab is effective and well tolerated in treating patients with ankylosing spondylitis who have advanced spinal fusion
Martin Rudwaleit et al.
RHEUMATOLOGY (2009)
Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature review
N. Zeboulon et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Do tumor necrosis factor inhibitors cause uveitis? A registry-based study
Lyndell L. Lim et al.
ARTHRITIS AND RHEUMATISM (2007)
Early clinical experience with leflunornide in uveitis
Mili Roy
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE (2007)
High-dose infliximab prophylaxis in endotoxin-induced uveitis
Manuel Diaz-Llopis et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2007)
Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation
Anat Galor et al.
OPHTHALMOLOGY (2006)
Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept
J Braun et al.
ARTHRITIS AND RHEUMATISM (2005)
Mycophenolate mofetil therapy for inflammatory eye disease
JE Thorne et al.
OPHTHALMOLOGY (2005)
A prospective trial of infliximab therapy for refractory uveitis - Preliminary safety and efficacy outcomes
EB Suhler et al.
ARCHIVES OF OPHTHALMOLOGY (2005)
Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop
DA Jabs et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
Incidence and prevalence of uveitis in Northern California - The Northern California Epidemiology of Uveitis Study
DC Gritz et al.
OPHTHALMOLOGY (2004)
The role of tumour necrosis factor (TNF-α) in experimental autoimmune uveoretinitis (EAU)
AD Dick et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2004)
分享论文
